Inflammatory Bowel Disease: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 1,303 matching trials) · https://research.opensourcemed.info/briefs/inflammatory-bowel-disease.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Vedolizumab 4 trials
- Anti-TNF Therapy 2 trials
- Mirikizumab 2 trials
- AB (antibiotics) 1 trial
- Adalimumab 1 trial
- Adecatumumab (MT-201) 1 trial
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Education, coaching and self-management 30 trials · 12 completed · 2 with results
- Dietary patterns and specific diets 42 trials · 16 completed · 1 with results
- Cognitive behavioural and related therapies 14 trials · 7 completed · 1 with results
- Probiotics, prebiotics and synbiotics 16 trials · 6 completed · 1 with results
- Nutrition counselling and food-based products 7 trials · 4 completed · 1 with results
- Yoga, tai chi, qigong and pilates 2 trials · 2 completed · 1 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- Vitamin D3
- Curcumin
- Resveratrol
Biomarkers reported
Direction in patients compared with the stated comparison group, as reported in the cited study.
- ANCA Antibodies higher · Pang et al. 2020
- ASCA Antibodies higher · Zholudev et al. 2004
- CRP higher · Singh et al. 2023
- ESR higher · Ondrejčáková et al. 2024
- Fecal Calprotectin higher · Tibble et al. 2001
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease… NCT06581328
- A Long-Term Extension Study of Vedolizumab in Children and Teenagers With… NCT06405087
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric… NCT04844606
- Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory… NCT07353853
- Automated Clinical Pathway for Inflammatory Bowel Disease Care NCT07167836
- Personalized B-fructan Diet in Inflammatory Bowel Disease Patients NCT05615779
What we don't know yet
Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.
- Supplements and nutraceuticals: inflammation and other biomarkers 27 trials, no results posted yet
- Exercise and physical activity: inflammation and other biomarkers 11 trials, no results posted yet